GlassScriptPhysician profile
Gordon G Wong
NPI 1447338447
$6,343.62
in general payments reported to CMS, 2019-2025
13 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $99.16 · 2021: $1,817 · 2022: $1,587 · 2023: $935 · 2024: $164 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312 · Entertainment: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.20 |
| Entertainment | $228.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,472.13 | 2019-2025 | Dailies Total1, Wavelight Refractive Suite, Total30 |
| Bausch & Lomb Americas INC. | $810.64 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $252.29 | 2020-2021 | |
| Optos, INC. | $228.37 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ocular Therapeutix, INC. | $220.19 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $113.34 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $111.69 | 2019-2022 | |
| Oyster Point Pharma, INC. | $42.40 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $23.65 | 2021 | |
| Allergan, INC. | $20.09 | 2021 | |
| Sight Sciences, INC. | $17.06 | 2025 | Tearcare System |
| Abbvie INC. | $16.56 | 2022 | |
| Thea Pharma INC. | $15.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.